|
Search
Collections
Benchmarks
Upload document
Caralizumab
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 abstract
Abstract
Combining nimotuzumab with PD-L1 inhibitors and chemotherapy to treat esophageal cancer: A retrospective study.
Org:
First Affiliated Hospital of Guangdong Pharmaceutical University,
